| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/03/2002 | EP1218402A1 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
| 07/03/2002 | EP1218398A1 Antisense modulation of pi3 kinase p110 beta expression |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218380A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 07/03/2002 | EP1218379A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218378A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218371A2 Di-substituted iminoheterocyclic compounds |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218368A1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 07/03/2002 | EP1218360A1 Triazine kinase inhibitors |
| 07/03/2002 | EP1218357A1 Quinazoline derivatives |
| 07/03/2002 | EP1218356A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/03/2002 | EP1218355A1 Therapeutic quinazoline derivatives |
| 07/03/2002 | EP1218354A1 Quinazoline derivatives and their use as pharmaceuticals |
| 07/03/2002 | EP1218352A1 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 07/03/2002 | EP1218348A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 07/03/2002 | EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 07/03/2002 | EP1218346A1 Pyrazole derivatives |
| 07/03/2002 | EP1218342A2 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218064A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218032A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218011A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP1217994A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1217902A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 07/03/2002 | EP1131062A4 Injectable propofol formulations |
| 07/03/2002 | EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines |
| 07/03/2002 | EP1059920B1 Use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 07/03/2002 | EP0983235B1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 07/03/2002 | EP0863769B1 Glycoconjugates as virus cell adhesion inhibitors |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | EP0812185B1 Use of angiogenesis suppressors for inhibiting hair growth |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
| 07/03/2002 | CN1356995A Substituted benzimidazole |
| 07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands |
| 07/03/2002 | CN1356981A Pharmaceutical compounds |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/03/2002 | CN1356974A Skin whitener |
| 07/03/2002 | CN1356908A Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 07/03/2002 | CN1356906A Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 07/03/2002 | CN1356904A Compsns. comprising mixture of bioflavonols |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356887A Niacinamide compsns. with reduced tack |
| 07/03/2002 | CN1356319A Process for preparing non-steroid glucocorticoid receptor regulator |
| 07/03/2002 | CN1356143A Emulsion-type lubricant and its application in medical rubber product |
| 07/03/2002 | CN1356129A Chinese medicine for comprehensively conditioning functions of human body and its preparing process |
| 07/03/2002 | CN1356104A Antalgic method by general medicine application |
| 07/03/2002 | CN1356103A 抗疲劳组合物 Anti-fatigue composition |
| 07/02/2002 | US6414161 Chemical intermediate in preparation of small molecules that inhibit interaction of celluar adhesion molecules thereby treating or preventing inflammatory and immune cell-mediated disease |
| 07/02/2002 | US6414157 Compounds having high affinity for 5-ht1b and 5-ht1c serotonin receptor; antidepressants |
| 07/02/2002 | US6414154 Tetraisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/02/2002 | US6414153 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease |
| 07/02/2002 | US6414149 Treating diabetes, treating or preventing diabetic complications |
| 07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
| 07/02/2002 | US6414126 C-aryl glucoside SGLT2 inhibitors and method |
| 07/02/2002 | US6414114 Useful as agents in oxidation-reduction equilibrium in cells; enzyme regulation in homeostasis |
| 07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
| 07/02/2002 | US6414030 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers |
| 07/02/2002 | US6414026 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6414020 Antiproteolytic amidino or derivative useful for treating pencreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof |
| 07/02/2002 | US6414011 Central nervous system disorders |
| 07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/02/2002 | US6413991 Antidiabetic agents; dietetics |
| 07/02/2002 | US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex. |
| 07/02/2002 | US6413982 4-substituted quinoline derivatives |
| 07/02/2002 | US6413979 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/02/2002 | US6413978 Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 07/02/2002 | US6413971 Antiproliferative, -carcinogenic, -tumor and -diabetic agents; binding to or modulating the human kinase insert-domain-containing receptor (kdr) or the murine fetal liver kinase 1 (flk-1) receptor; vasculogenesis; angiogenesis |
| 07/02/2002 | US6413966 Serotonergic and central dopaminergic activity; affinity for 5ht1a and 5ht2 serotonin and d2 dopamine receptors; atypical antipsychotics; schizophrenia |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors |
| 07/02/2002 | US6413957 Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones |
| 07/02/2002 | US6413956 Substituted 4-oxo-quinoline-3-carboxamides |
| 07/02/2002 | US6413952 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 07/02/2002 | US6413948 Central nervous system disorders |
| 07/02/2002 | US6413940 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413737 Ecarin prothrombin protease and methods |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |